Ever since spinning off from Abbott Laboratories in 2013, AbbVie has made culture a strategic business priority.

The logic is sound for a business that relies on the skill and ideas of its people to find and develop new drug candidates, which is vital for long-term growth in pharmaceuticals.

“We think sustained performance will be driven by a consistent culture,” explains Jason Smith, AbbVie’s senior vice president and head of Europe commercial operations.

“We’re not looking for a one- or two-year view on financial performance,” at the expense of employee experience, Smith says. “You may win for a quarter or a year, but you’re not going to sustain the performance. You’ll see people less engaged. You’ll see attrition.”

It’s a principle that is doubly important given AbbVie’s highly

See Full Page